Abstract
The objectives of this study were to analyze the clinical features of patients with bone involved lymphoma and identify the prognostic factors and to explore the optimized treatment strategy for bone involved lymphoma.A total of 1948 patients with lymphoma in our cancer center from September 2006 to October 2017 were retrospectively evaluated. Among these, 109 patients with skeletal involvement in lymphoma were enrolled. According to the pathologic subtypes, the patients were divided into 3 subgroups: classic Hodgkin lymphoma (cHL), B-cell non-Hodgkin lymphoma (B-NHL), and T-cell non-Hodgkin lymphoma (T-NHL). The clinical characteristics and overall survival (OS) of 3 groups of patients were reviewed, and the prognostic factors were analyzed.There were 9 (3 unifocal, 6 multifocal) patients with primary bone lymphoma. The 5-year OS of cHL, B-NHL, and T-NHL patients was 88.24%, 54.09%, and 61.58%, respectively. Advanced stage, elevated lactate dehydrogenase (LDH), age above 60, high International Prognostic Index score, and treatment without radiotherapy for the bone involved were significant poor prognostic factors for OS of all patients in univariate analysis. There was a trend toward better OS not only in limited-stage but als...Continue Reading
References
Jan 1, 1975·Radiology·J C Probert, B R Parker
Jun 1, 1987·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·N P MendenhallR R Million
Dec 15, 1986·Cancer·M L OstrowskiW F Taylor
Oct 1, 1982·European Journal of Cancer & Clinical Oncology·L EndrizziV Fosser
Dec 1, 1993·British Journal of Cancer·R GarcíaJ F San Miguel
May 16, 2006·Cancer·Kathryn BealJoachim Yahalom
Jan 24, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonUNKNOWN International Harmonization Project on Lymphoma
Jun 1, 2007·Applied Immunohistochemistry & Molecular Morphology : AIMM·Carlos BarrionuevoEduardo-Alfredo Zevallos-Giampietri
Jul 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie VoseUNKNOWN International T-Cell Lymphoma Project
Nov 21, 2008·Leukemia & Lymphoma·Joseph P CatlettVera Malkovska
Jul 7, 2009·Hematology/oncology Clinics of North America·William R Macon
Sep 8, 2009·Journal of Clinical Pathology·F H HeyningP M Jansen
Jul 1, 2011·The American Journal of Surgical Pathology·Gabriela GualcoCarlos E Bacchi
Aug 23, 2012·American Journal of Clinical Pathology·Jian SunJie Chen
Sep 7, 2012·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Janet E BrownRobert E Coleman
Apr 18, 2013·Clinical Orthopaedics and Related Research·Emre DemircayHenry Degroot
Sep 26, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerhard HeldMichael Pfreundschuh
Dec 4, 2013·Leukemia & Lymphoma·Silvia GoviUNKNOWN International Extranodal Lymphoma Study Group
Dec 18, 2013·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Chee Yeong Lim, Keh Oon Ong
Jan 5, 2014·British Journal of Haematology·Carlo MessinaUNKNOWN International Extranodal Lymphoma Study Group (I.E.L.S.G.)
Feb 26, 2014·The Oncologist·Marta Bruno VentreUNKNOWN International Extranodal Lymphoma Study Group
Jul 22, 2014·Mediterranean Journal of Hematology and Infectious Diseases·Annarosa CuccaroStefan Hohaus
Feb 24, 2015·Cancer Treatment Reviews·Carlo MessinaAndrés J M Ferreri
Dec 25, 2015·The New England Journal of Medicine·Michael SchaapveldFlora E van Leeuwen
Sep 1, 2013·Journal of Bone Oncology·Anshu JainVarsha Narula
Jul 6, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·U VitoloUNKNOWN ESMO Guidelines Committee
Jan 21, 2017·Molecular and Clinical Oncology·Suoyuan LiYingqi Hua